Viewing Study NCT01863160

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-04-16 @ 6:41 PM
Study NCT ID: NCT01863160
Status: COMPLETED
Last Update Posted: 2014-02-20
First Post: 2013-05-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers
Sponsor: Shulov Innovate for Science Ltd. 2012
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None Tolerability View
None Pharmacokinetic profile View
None ZEP-3 Cream (0.1% and 1.0%) View
None administered topically View